| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 54,356 | 43,763 | 39,070 | 36,748 | | Cost of Revenue | 36,446 | 26,678 | 22,798 | 20,933 | | | Gross Profit | 17,910 | 17,085 | 16,272 | 15,815 | | | Operating Expenses | | Research Development | 1,207 | 1,603 | 1,406 | 2,036 | | Selling General and Administrative | 13,578 | 11,500 | 13,150 | 13,006 | | Non Recurring |
-
| 5 | (5) |
-
| | Others | 1,818 | 1,811 | 1,811 | 1,957 | | | | Total Operating Expenses |
-
| 14,919 | 16,362 |
-
| | | | Operating Income or Loss | 1,307 | 2,166 | (90) | (1,184) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 472 | 801 | (4,744) | (5,611) | | Earnings Before Interest And Taxes | 1,779 | 2,967 | (4,834) | (6,795) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 1,779 | 2,967 | (4,834) | (6,795) | | Income Tax Expense | (32) | 82 | 201 | 445 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,811 | 2,885 | (5,035) | (7,240) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (694) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,811 | 2,885 | (5,035) | (7,934) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,811 | $2,885 | ($5,035) | ($7,934) |
|
0.02% Nasdaq 
0.08 (0.97%) 
Income Statement
